Related Experiment Video
Updated: May 27, 2026

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
Published on: March 24, 2023
Toward understanding Machado-Joseph disease
Maria do Carmo Costa1, Henry L Paulson
1Department of Neurology, University of Michigan, A. Alfred Taubman Biomedical Sciences Research Building-BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. mariadoc@med.umich.edu
Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3, involves a toxic expansion in the ATXN3 protein. Understanding ATXN3 dysfunction is key to developing therapies for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is a common inherited neurodegenerative disorder.
- It is characterized by a CAG repeat expansion in the ATXN3 gene, leading to an abnormal polyglutamine (polyQ) tract in the ATXN3 protein.
Purpose of the Study:
- This review focuses on the function and dysfunction of the ATXN3 protein in MJD.
- It also highlights recent advances in potential therapeutic strategies for MJD.
Main Methods:
- The review synthesizes current knowledge on ATXN3's role as a deubiquitinating enzyme (DUB) and its involvement in proteostasis.
- It discusses findings from various cellular and animal models of MJD to understand ATXN3 dysfunction.
Main Results:
- ATXN3's normal function involves regulating protein stability and activity in pathways related to proteotoxic stress, aging, and cell differentiation.
- PolyQ expansion in ATXN3 alters its conformation, leading to impaired interactions and the formation of insoluble aggregates.
Conclusions:
- While significant progress has been made, the precise molecular mechanisms of ATXN3-induced neurotoxicity in MJD remain unclear.
- Further understanding of these complex mechanisms is crucial for developing effective treatments for this fatal disease.
Related Concept Videos
Huntington Disease l: Introduction
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cytomegalovirus Disease
Sex-linked Disorders
Parkinson Disease ll: Pathophysiology

